date
major
work
rna
viru
replic
fidel
focus
viral
rna
polymeras
potenti
role
viral
replicas
protein
process
poorli
understood
previou
studi
use
resist
broadspectrum
rna
mutagen
ribavirin
identifi
polymeras
increas
fidel
avoid
misincorpor
base
analogu
identifi
novel
variant
alphaviru
viral
helicaseproteas
nonstructur
protein
oper
concert
viral
polymeras
alter
replic
complex
fidel
function
linkag
conserv
among
alphaviru
genu
purifi
chikungunya
viru
present
delay
helicas
activ
highfidel
enzym
yet
purifi
replic
complex
manifest
stronger
rna
polymer
kinet
mutagen
nucleosid
analog
ribavirin
also
affect
intracellular
nucleotid
pool
address
link
nucleotid
deplet
replic
fidel
use
purin
pyrimidin
biosynthesi
inhibitor
highfidel
virus
resist
condit
viral
growth
could
rescu
addit
exogen
nucleosid
suggest
mutagenesi
base
analogu
requir
nucleotid
pool
deplet
studi
describ
novel
function
highlight
role
compon
replic
complex
regul
viral
replic
fidel
suggest
virus
alter
replic
complex
fidel
overcom
intracellular
nucleotidedeplet
condit
previou
studi
use
rna
mutagen
ribavirin
select
drugresist
variant
highlight
essenti
role
viral
rnadepend
rna
polymeras
regul
replic
fidel
howev
role
viral
replicas
compon
replic
fidel
studi
detail
identifi
rna
mutagenresist
variant
helicaseproteas
confer
increas
fidel
yet
could
oper
manner
highfidel
polymeras
show
alphaviru
helicas
key
compon
fidelityregul
machineri
data
show
rna
mutagen
activ
compound
ribavirin
coupl
potenti
nucleotid
deplet
rna
virus
finetun
replic
fidel
face
intracellular
environ
deplet
nucleotid
r
na
virus
rapidli
gener
larg
amount
genet
divers
maintain
genom
integr
process
thu
far
essenti
restrict
function
polymeras
littl
known
regard
viral
cellular
compon
might
regul
fidel
particular
involv
alphaviru
replic
use
rna
mutagen
alter
mutat
rate
fidel
determin
within
viral
polymeras
mani
rna
virus
identifi
includ
footandmouth
diseas
viru
polioviru
coxsacki
b
viru
influenza
viru
human
enteroviru
chikungunya
viru
chikv
sindbi
viru
sinv
mutagen
compound
ribavirin
base
analog
provok
mutat
downstream
replic
cycl
misincorpor
genom
howev
ribavirin
also
function
imp
dehydrogenas
impdh
inhibitor
enzym
necessari
de
novo
purin
biosynthesi
specif
intracellular
gtp
level
wherea
inhibit
thymidyl
synthas
lead
decreas
dttp
increas
dutp
thu
anoth
imbal
nucleotid
pool
thu
addit
avoid
incorpor
mutagen
base
analog
resist
may
aris
overcom
imbal
nucleotid
pool
resist
could
achiev
whether
variant
would
present
alter
fidel
known
chikv
alphaviru
member
togavirida
famili
chikv
envelop
positivestrand
rna
viru
contain
genom
encod
gene
product
viral
replic
includ
four
nonstructur
protein
requir
rna
replic
six
structur
protein
capsid
tf
necessari
virion
product
nonstructur
protein
contribut
membran
bind
cap
event
sinc
viral
guanylyland
methyltransferas
also
requir
negativestrand
rna
synthesi
multifunct
protein
exhibit
helicas
ntpase
proteas
activ
well
carri
carboxytermin
put
methyltransferaselik
domain
addit
role
precis
viral
polyprotein
cleavag
process
initi
step
replic
also
requir
cellular
transcript
shutoff
infect
harbor
macrodomain
zinc
bind
domain
hypervari
region
wherea
viral
rnadepend
rna
polymeras
rdrp
four
nonstructur
protein
along
host
cofactor
function
togeth
orchestr
effici
genom
replic
similar
studi
previous
util
rna
mutagen
ribavirin
studi
drugresist
mutat
alphavirus
chikv
sinv
identifi
residu
rdrp
key
determin
polymeras
fidel
interestingli
initi
screen
drugresist
variant
identifi
addit
variant
protein
character
present
studi
found
variant
resist
rna
mutagen
increas
fidel
mechan
independ
viral
polymeras
addit
biochem
assay
show
highfidel
reduc
helicas
activ
wherea
isol
highfidel
replic
complex
increas
replic
kinet
resist
low
nucleotid
concentr
final
found
highfidel
variant
resist
nucleotid
biosynthesi
inhibitor
mycophenol
acid
brequinar
suggest
variant
select
due
abil
util
surviv
low
imbalanc
nucleotid
condit
taken
togeth
data
provid
novel
role
regul
alphaviru
fidel
expand
knowledg
viral
compon
requir
regul
process
addit
result
show
rna
virus
alter
biolog
regul
replic
fidel
intracellular
environ
chang
mammalian
vero
hela
cell
line
maintain
dulbecco
modifi
eagl
medium
dmem
gibco
supplement
newborn
calf
serum
gibco
penicillinstreptomycin
sigma
co
wildtyp
wt
chikv
gener
la
reunion
strain
infecti
clone
previous
describ
chikv
mutant
gener
sitedirect
mutagenesi
infecti
clone
use
quikchang
ii
xl
sitedirect
mutagenesi
kit
stratagen
newli
gener
dna
plasmid
sanger
sequenc
full
gatc
biotech
confirm
mutagenesi
ensur
secondsit
mutat
introduc
sinv
mutant
construct
fashion
wildtyp
infecti
clone
plasmid
contain
cdna
chikv
sinv
infecti
clone
linear
noti
xhoi
respect
purifi
phenolchloroform
extract
ethanol
precipit
subsequ
use
vitro
transcript
viral
rna
use
mmessag
mmachin
kit
ambion
rna
purifi
phenolchloroform
extract
ethanol
precipit
quantifi
dilut
gl
store
rna
transfect
cell
treat
trypsin
wash
twice
icecold
phosphatebuff
salin
pb
resuspend
concentr
cellsml
icecold
pb
cell
ml
mix
g
vitrotranscrib
viral
rna
place
gap
cuvett
electropor
kv
f
infinit
xcell
gene
pulser
biorad
cell
allow
recov
min
room
temperatur
mix
ml
prewarm
medium
place
flask
h
incub
viru
titer
determin
standard
plaqu
assay
brief
serial
dilut
viru
dmem
incub
confluent
monolay
vero
cell
h
incub
cell
overlaid
agaros
dissolv
dmem
newborn
calf
serum
follow
incub
h
cell
fix
formalin
agaros
plug
remov
plaqu
visual
addit
crystal
violet
gener
work
viral
stock
viru
sampl
passag
confluent
monolay
cell
titer
determin
describ
sampl
divid
aliquot
store
use
virus
passag
three
time
cell
fulli
sequenc
ensur
mutat
stabil
secondsit
mutat
drug
sensit
assay
hela
cell
cellswel
tissu
cultur
plate
pretreat
either
medium
contain
drug
medium
contain
drug
rna
mutagen
nucleotid
biosynthesi
inhibitor
incub
time
concentr
follow
h
ribavirin
sigma
gml
min
brequinar
mycophenol
acid
sigma
posttreat
medium
remov
cell
inocul
viru
dmem
multipl
infect
moi
h
viru
incub
medium
contain
compound
ad
cell
incub
h
viru
harvest
h
mean
titer
obtain
determin
tissu
cultur
infect
dose
tcid
brief
tissu
cultur
plate
plate
viru
vero
cellswel
virus
serial
dilut
dilut
dmem
dilut
distribut
row
plate
well
receiv
l
dilut
viru
virus
cell
incub
day
co
incub
cell
fix
l
formalin
medium
remov
l
crystal
violet
ad
well
ribavirin
sensit
assay
virus
exhibit
signific
sensit
resist
compar
wild
type
p
greater
either
ribavirin
consid
potenti
fidel
variant
mutat
frequenc
estim
mutat
frequenc
molecular
clone
determin
mutat
frequenc
mutant
electropor
tandem
cell
supernat
collect
h
later
viral
rna
extract
describ
chikv
region
correspond
nucleotid
amplifi
region
genom
use
forward
primer
revers
primer
sinv
analog
region
amplifi
use
forward
primer
revers
primer
base
fragment
includ
analysi
amplifi
fragment
purifi
describ
l
product
modifi
aoverhang
addit
reaction
l
amplitaq
gold
buffer
l
mm
datp
modifi
product
clone
use
topota
clone
kit
invitrogen
singl
coloni
pick
sequenc
mutat
frequenc
determin
previous
describ
mutat
frequenc
hela
vero
cell
perform
similar
manner
popul
divers
mutat
frequenc
deep
sequenc
estim
popul
divers
variant
deep
sequenc
cdna
librari
prepar
use
maxima
h
minu
revers
transcriptas
invitrogen
rna
extract
viru
gener
passag
three
time
cell
viral
genom
pcr
amplifi
use
highfidel
polymeras
phusion
gener
one
amplicon
span
major
chikv
genom
pcr
product
fragment
fragmentas
multiplex
cluster
sequenc
lane
illumina
cbot
gaiix
technolog
analyz
establish
deepsequenc
data
analysi
tool
inhous
script
briefli
perbas
phred
qualiti
score
util
trim
base
error
probabl
higher
sequenc
fewer
base
trim
discard
purpos
use
fastqmcf
tool
eautil
toolkit
http
codegooglecompeautil
align
step
perform
use
burrowswheel
align
pileup
analysi
perform
use
samtool
pileup
done
vivan
bioinformat
pipelin
use
collect
data
per
posit
calcul
varianc
nucleotid
posit
root
mean
squar
deviat
valu
use
determin
mean
varianc
standard
error
across
whole
genom
viral
replic
extracellular
rna
synthesi
viru
growth
evalu
cell
titer
determin
calcul
tcid
vero
cell
describ
virus
dilut
achiev
moi
serumfre
medium
incub
cell
type
h
incub
viru
remov
cell
wash
twice
pb
complet
medium
ad
h
postinfect
supernat
collect
titrat
rna
extract
chikv
genom
copi
number
determin
extract
viral
rna
supernat
time
point
use
trizol
reagent
perform
quantit
revers
transcriptionpcr
qrtpcr
use
taqman
rnatoct
kit
appli
biosystem
cycl
threshold
c
valu
determin
duplic
base
amplif
transcript
use
forward
revers
primer
probe
previous
publish
standard
curv
perform
run
use
sampl
vitrotranscrib
chikv
rna
pulsechas
analysi
cell
infect
wildtyp
chikv
variant
moi
infect
medium
compris
glasgow
minimum
essenti
medim
penicillinstreptomycin
mm
hepe
ph
bovin
serum
albumin
h
postinfect
cell
wash
starvat
medium
methionineand
cysteinefre
dmem
life
technolog
mm
hepe
ph
incub
starvat
medium
min
starvat
medium
replac
starvat
medium
contain
ci
methioninecystein
mixtur
perkinelm
min
follow
addit
chase
medium
starvat
medium
contain
mm
methionin
mm
cystein
time
min
postchas
cell
wash
pb
lyse
sodium
dodecyl
sulfat
sd
boil
min
pass
small
gaug
needl
centrifug
min
rpm
immunoprecipit
clarifi
lysat
dilut
net
buffer
mm
tri
ph
mm
nacl
mm
edta
ph
igep
preclear
protein
asepharos
sigma
h
antibodi
chikv
ad
sampl
incub
overnight
antibodi
incub
protein
asepharos
ad
h
bead
pellet
centrifug
wash
three
time
net
buffer
mm
tri
ph
mm
nacl
mm
edta
ph
igep
resuspend
laemmli
buffer
protein
denatur
boil
min
separ
sdspage
gel
gel
fix
destain
solut
methanol
acet
acid
wash
h
dri
vacuum
dri
expos
phosphoscreen
visual
use
typhoon
trio
scanner
ge
healthcar
imag
quantifi
use
imagej
subcellular
fraction
immunoblot
cell
infect
wildtyp
chikv
doubl
mutant
moi
incub
h
medium
remov
cell
wash
pb
treat
trypsin
cell
harvest
centrifug
g
min
supernat
remov
cell
wash
icecold
pb
cell
resuspend
swell
buffer
mm
trishcl
ph
mm
nacl
mm
mgcl
contain
complet
proteas
inhibitor
roch
incub
ice
min
lyse
dounc
homogen
homogen
sampl
centrifug
g
min
supernat
remov
centrifug
g
min
sampl
contain
membran
fraction
resuspend
storag
buffer
mm
sucros
mm
trishcl
ph
mm
nacl
complet
proteas
inhibitor
total
protein
concentr
determin
bradford
assay
biorad
membran
fraction
adjust
mg
total
proteinml
divid
aliquot
store
immunoblot
sampl
mix
laemmli
buffer
biorad
contain
sampl
heat
min
separ
sdspage
transfer
nitrocellulos
membran
biorad
membran
block
nonfat
milk
trisbuff
salin
mm
trishcl
ph
mm
edta
mm
nacl
contain
tween
tbst
incub
overnight
antibodi
capsid
prepar
either
inhous
kindli
provid
p
gorman
obtain
commerci
sourc
coxiv
cell
signal
tubulin
sigma
dilut
block
buffer
membran
wash
extens
tbst
incub
secondari
antirabbit
horseradish
peroxidaseantibodi
millipor
wash
three
time
tbst
membran
develop
use
supersign
west
pico
chemiluminesc
substrat
thermo
scientif
purif
chikv
variant
mutat
introduc
express
vector
sitedirect
mutagenesi
use
primer
describ
express
purif
wildtyp
neg
control
perform
previous
describ
bacteri
cell
harvest
overnight
cultur
suspend
lysi
buffer
lyse
cell
use
french
press
lysat
clarifi
highspe
centrifug
subsequ
protein
purifi
ni
affin
ion
exchang
size
exclus
describ
previous
puriti
recombin
protein
analyz
standard
page
concentr
protein
sampl
measur
nanodrop
thermo
scientif
take
consider
extinct
coeffici
sampl
flash
frozen
store
g
purifi
wildtyp
wt
enzym
analyz
sdspage
see
fig
circular
dichroism
spectroscopi
perform
previous
describ
ensur
wt
variant
compar
fold
pattern
chikv
vitro
proteas
cleavag
assay
substrat
cleavag
design
purifi
previous
describ
protein
cleavag
assay
carri
incub
ng
purifi
variant
g
substrat
assay
buffer
mm
hepe
ph
mm
dithiothreitol
dtt
final
volum
l
reaction
mixtur
incub
min
h
follow
addit
laemmli
buffer
sampl
boil
resolv
page
gel
process
previous
describ
continu
proteas
assay
perform
use
fluoresc
reson
energi
transfer
fret
base
substrat
repres
chikv
cleavag
site
fig
briefli
peptid
substrat
excit
wavelength
nm
emiss
wavelength
nm
interv
min
total
period
h
final
data
normal
noenzym
control
express
rel
fluoresc
unit
rfu
vitro
rna
helicas
assay
rna
oligonucleotid
substrat
overhang
helicas
assay
prepar
describ
previous
helicas
assay
pm
concentr
rna
substrat
incub
nm
purifi
wt
variant
reaction
buffer
contain
mm
hepe
ph
mm
dtt
mm
nacl
final
volum
l
reaction
mixtur
preincub
min
reaction
mixtur
incub
without
atpmg
mm
final
concentr
aliquot
remov
indic
time
point
reaction
stop
process
describ
previous
imag
quantifi
use
imagej
ntpase
assay
ntpase
assay
perform
essenti
describ
previous
use
enzcheck
phosphat
assay
kit
life
technolog
accord
manufactur
protocol
howev
final
reaction
volum
adjust
l
brief
ng
purifi
protein
incub
reaction
buffer
mm
trishcl
ph
mm
mgcl
nan
contain
ribosid
substrat
mesg
u
purin
nucleosid
phosphorylas
final
volum
l
initi
incub
min
continu
spectrophotometr
measur
carri
use
ultrospec
spectrophotomet
ge
healthcar
immedi
addit
l
mm
nucleosid
triphosph
ntp
substrat
vitro
replic
assay
portion
g
isol
membran
ad
reaction
mixtur
contain
reaction
buffer
mm
trishcl
ph
mm
kcl
mm
mgcl
mm
dtt
g
actinomycin
dml
mm
creatin
phosphat
g
creatin
phosphokinaseml
mm
atp
mm
gtp
mm
ctp
utp
ci
p
utp
perkinelm
l
rnaseout
final
concentr
incub
indic
time
examin
vitro
replic
low
nucleotid
concentr
reaction
perform
describ
atp
ctp
gtp
concentr
rna
extract
phenolchloroform
unincorpor
nucleotid
remov
use
illustra
microspin
hr
column
ge
healthcar
separ
tae
agaros
gel
gel
dri
expos
autoradiographi
film
genom
subgenom
rna
identifi
size
use
vitrotranscrib
rna
standard
statist
test
experi
perform
triplic
unless
note
otherwis
statist
note
appli
perform
graphpad
prism
p
valu
consid
signific
alphaviru
nonstructur
protein
regul
genom
replic
fidel
previou
studi
identifi
novel
mutagen
resist
variant
chikv
posit
suggest
may
play
import
role
maintain
replic
fidel
address
possibl
introduc
substitut
infecti
clone
measur
mutat
frequenc
result
viral
popul
multipl
cell
type
compar
wildtyp
wt
chikv
fig
variant
manifest
increas
fidel
everi
cell
type
indic
inde
involv
regul
chikv
genom
fidel
furthermor
given
chikv
highfidel
polymeras
variant
novel
variant
isol
antivir
treatment
address
addit
role
resist
rna
mutagen
ribavirin
fig
individu
variant
resist
drug
combin
two
variant
dm
enhanc
address
mutat
frequenc
viru
absenc
black
bar
presenc
white
bar
ribavirin
examin
extent
mutagenesi
fig
expect
wildtyp
popul
mutagen
drug
greatest
degre
wherea
higherfidel
variant
resist
mutagenesi
previous
report
singl
variant
led
even
higherfidel
phenotyp
variant
interestingli
doubl
mutant
complet
resist
mutagen
activ
ribavirin
data
suggest
two
protein
work
togeth
regul
fidel
nonredund
mechan
mutat
may
select
base
antimetabol
activ
ribavirin
given
seemingli
synergist
role
regul
fidel
sought
determin
whether
fidelityincreas
mutat
could
compens
lowfidel
activ
mutat
variant
polymeras
fig
e
analyz
took
advantag
previous
identifi
variant
increas
mutat
frequenc
found
combin
lowfidel
highfidel
yield
intermedi
mutat
frequenc
suggest
two
viral
compon
contribut
replic
fidel
final
interest
whether
novel
function
conserv
among
alphaviru
genu
protein
align
alphaviru
reveal
chikv
close
rel
onyong
nyong
viru
onnv
also
contain
glycin
correspond
posit
wherea
alphavirus
contain
glutam
acid
fig
interestingli
increas
fidel
observ
confer
chang
neg
charg
aspart
acid
mirror
charg
natur
occur
glutam
acid
alphavirus
therefor
hypothes
essenti
requir
neg
charg
posit
maintain
fidel
address
introduc
glutam
acid
posit
chikv
observ
decreas
mutat
frequenc
similar
variant
fig
previou
studi
observ
sinv
maintain
lower
basal
mutat
frequenc
higher
nativ
fidel
chikv
chang
analog
residu
sinv
glutam
acid
glycin
normal
observ
chikv
mutat
frequenc
sinv
nearli
doubl
fig
addit
found
sinv
chang
sensit
ribavirin
treatment
fig
phenotyp
confirm
reduc
replic
fidel
taken
togeth
data
implic
key
regul
alphaviru
replic
fidel
function
togeth
maintain
genom
integr
highfidel
chikv
variant
increas
vitro
replicas
activ
increas
access
nucleotid
studi
role
highfidel
variant
function
viral
life
cycl
determin
onestep
growth
curv
address
viral
replic
rna
product
yet
found
differ
variant
fig
b
howev
rule
differ
may
occur
intracellularli
earli
infect
function
viral
proteas
earli
infect
cleav
viral
polyprotein
tempor
manner
regul
multipl
step
rna
replic
address
kinet
polyprotein
process
perform
pulsechas
experi
wt
variant
look
specif
cleavag
dur
ing
initi
step
infect
yet
differ
observ
fig
addit
viral
proteas
function
helicas
ntpase
address
function
took
advantag
recent
develop
biochem
assay
use
purifi
purifi
wt
variant
found
differ
protein
puriti
sdspage
fig
protein
fold
circular
dichroism
spectroscop
analysi
fig
suggest
mutat
affect
protein
structur
next
address
vitro
proteas
activ
use
substrat
contain
cleavag
site
link
two
larger
protein
fragment
found
differ
proteas
activ
min
earli
event
h
late
event
confirm
result
tissu
cultur
pulsechas
analysi
fig
interestingli
use
sensit
fret
base
proteas
assay
use
cleavag
site
observ
slight
increas
proteas
activ
variant
fig
variant
use
neg
control
addit
address
helicas
activ
variant
found
differ
helicas
activ
presenc
absenc
atp
mg
incub
h
fig
b
address
perform
kinet
assay
look
earli
event
rna
unwind
fig
found
variant
present
impair
helicas
function
earli
boost
phase
unwind
plateau
lower
level
compar
wildtyp
final
look
rel
ntpase
activ
purifi
protein
found
highfidel
variant
exhibit
increas
ntpase
activ
ntp
substrat
vitro
fig
f
variant
use
neg
control
data
suggest
may
play
role
replic
complex
abil
hydrolyz
nucleotid
howev
sinc
nonstructur
protein
yet
success
biochem
purifi
test
vitro
could
test
altern
approach
isol
function
replic
complex
differenti
centrifug
infect
cell
determin
kinet
vitro
rna
synthesi
biochem
characterist
complex
contain
equal
amount
viral
protein
fig
found
highfidel
variant
doubl
mutant
rapid
kinet
compar
wildtyp
wherea
variant
intermedi
phenotyp
fig
c
increas
replic
kinet
ntpase
activ
lead
us
hypothes
highfidel
variant
better
abl
access
util
nucleotid
pool
increas
overal
rate
polymer
ribavirin
known
deplet
gtp
pool
hypothes
increas
polymer
limit
ntp
condit
could
lead
resist
observ
presenc
ribavirin
studi
incub
isol
replic
complex
low
nucleotid
concentr
address
amount
rna
synthes
vitro
fig
e
found
wherea
wildtyp
replic
complex
activ
reduc
roughli
nucleotid
limit
activ
three
highfidel
variant
reduc
greater
extent
condit
fig
taken
togeth
data
suggest
highfidel
variant
may
reduc
replicas
activ
becom
select
nucleotid
pool
replic
effici
even
low
nucleotid
concentr
chikv
highfidel
replicas
variant
confer
resist
inhibitor
nucleosid
biosynthesi
variant
select
presenc
ribavirin
rna
mutagen
also
purin
biosynthesi
inhibitor
therefor
hypothes
antivir
effect
ribavirin
viral
growth
least
partial
complement
addit
exogen
nucleosid
inde
found
viral
growth
highfidel
variant
increas
low
concentr
guanosin
high
concentr
virus
includ
wild
type
rescu
fig
control
ad
uridin
unabl
rescu
viral
growth
extent
guanosin
data
reinforc
previou
studi
antivir
effect
ribavirin
contribut
two
level
primari
level
nucleotid
deplet
secondari
level
rna
mutagen
result
obtain
ribavirin
treatment
conjunct
rescu
addit
nucleotid
suggest
variant
may
advantag
nucleotidedeplet
cell
similar
observ
measur
mutat
frequenc
presenc
ribavirin
biochem
assay
thu
sought
determin
whether
variant
resist
nucleotidedeplet
compound
use
mycophenol
acid
brequinar
nucleosid
analogu
mycophenol
acid
inhibit
impdh
act
analog
ribavirin
deplet
gtp
pool
contrast
brequinar
compound
act
inhibit
dihydroorot
dehydrogenas
key
enzym
pyrimidin
synthesi
deplet
ctp
ttp
treat
cell
viral
infect
compound
found
highfidel
variant
doubl
mutant
resist
nucleotidedeplet
compound
fig
c
similar
observ
ribavirin
treatment
interestingli
highfidel
variant
resist
pyrimidin
deplet
addit
variant
enhanc
resist
singl
mutat
suggest
may
function
independ
condi
tion
furthermor
viral
growth
restor
addit
relev
exogen
nucleosid
wherea
addit
irrelev
nucleosid
effect
restor
viral
growth
confirm
nucleotid
deplet
lead
viral
attenu
taken
togeth
data
show
highfidel
variant
resist
nucleotidedeplet
condit
select
variant
presenc
compound
suggest
rna
virus
regul
fidel
compens
intracellular
chang
vast
major
work
focus
rna
viru
replic
fidel
highlight
essenti
role
rdrp
maintain
genom
integr
past
work
larg
facilit
select
virus
resist
rna
mutagen
thu
yield
polymeras
resist
nucleosid
analogu
misincorpor
previou
studi
passag
chikv
presenc
mutagen
order
identifi
highfidel
alphaviru
polymeras
unexpectedli
process
uncov
variant
helicas
proteas
addit
highfidel
polymeras
variant
explor
role
variant
resist
rna
mutagen
fluctuat
nucleotid
pool
fidel
found
singl
substitut
led
resist
sever
rna
mutagen
well
nucleotid
synthesi
inhibitor
addit
variant
increas
fidel
chikv
multipl
cell
type
provid
novel
role
protein
viral
life
cycl
demonstr
nonstructur
protein
play
import
role
rna
replic
fidel
asid
polymeras
one
possibl
explan
chang
fidel
could
due
chang
physic
interact
particularli
sinc
mutat
alway
found
genom
origin
screen
resist
ribavirin
nonetheless
rule
possibl
differ
physic
interact
bind
affin
viral
nonstructur
protein
replic
complex
interestingli
mutat
sinv
confer
ribavirin
resist
describ
would
interest
test
whether
mutat
also
alter
viral
replic
fidel
mechan
similar
describ
current
nonpolymeras
fidel
determin
rna
virus
describ
coronavirus
uniqu
proofread
rnase
exon
manipul
exon
viral
cofactor
yield
variant
alter
fidel
helicaselik
accessori
protein
hand
common
across
mani
rna
virus
may
gener
mechan
complement
rna
polymeras
fidel
variant
confer
resist
ribavirin
addit
highfidel
polymeras
variant
increas
resist
mutagen
support
two
protein
function
link
modul
replic
fidel
complementari
mechan
highlight
addit
increas
fidel
doubl
mutant
contain
highfidel
polymeras
restor
wildtypelik
mutat
frequenc
doubl
mutant
contain
lowfidel
polymeras
fact
highfidel
doubl
mutant
show
sign
mutagenesi
presenc
ribavirin
result
suggest
highfidel
replic
complex
select
incorpor
nucleotid
way
ribavirin
enter
replic
complex
incorpor
grow
rna
strand
possibl
due
select
steric
hindranc
increas
affin
intracellular
nucleotid
importantli
data
suggest
mutagen
effect
base
analog
result
misincorpor
potenti
condit
nucleotid
deplet
natur
base
may
avail
access
find
import
optim
design
futur
nucleosid
analogu
either
close
resembl
natur
nucleotid
andor
increas
effect
natur
nucleotid
pool
addit
role
regul
chikv
replic
fidel
interest
whether
characterist
share
alphavirus
previou
studi
observ
mutat
frequenc
sinv
natur
lower
chikv
amino
acid
sequenc
align
region
sever
alphavirus
indic
except
onnv
alphavirus
contain
neg
charg
glutam
acid
instead
glycin
fig
neg
charg
residu
similar
aspart
acid
select
ribavirin
treatment
suggest
neg
charg
posit
play
import
role
maintain
replic
fidel
inde
chang
variant
aspart
glutam
acid
mimic
alphavirus
obtain
highfidel
phenotyp
furthermor
chang
glutam
acid
sinv
glycin
increas
mutat
frequenc
sinv
appreci
confirm
role
residu
protein
determin
replic
fidel
viru
genu
importantli
manipul
residu
genuswid
determin
fidel
mutat
variant
alphavirus
could
easili
obtain
mutat
strain
known
result
attenu
vivo
could
provid
novel
therapeut
vaccin
strategi
understand
mechan
highfidel
variant
chang
mutat
frequenc
use
biochem
system
use
studi
varieti
aspect
biolog
use
system
identifi
differ
rel
helicas
ntpase
activ
variant
observ
trend
increas
ntpase
activ
nucleotid
reduct
helicas
activ
vitro
overal
increas
ntpase
activ
combin
wt
polymeras
rel
lower
fidel
may
provid
support
replic
complex
sensit
ribavirin
misincor
porat
among
highfidel
virus
compar
fig
wherea
combin
yield
complex
larg
unabl
acquir
ribavirin
addit
slower
helicas
activ
may
provid
basi
select
nucleotid
incorpor
howev
note
although
result
intrigu
system
robust
suffici
studi
purifi
lack
compon
replic
complex
yet
success
express
vitro
miss
compon
like
influenc
mani
aspect
biolog
thu
vitro
result
inform
interpret
mind
given
lack
biochem
system
examin
isol
address
replic
activ
isol
activ
replic
complex
infect
cell
contrast
previou
work
show
reduc
replic
rate
increas
select
fidel
found
highfidel
replic
complex
increas
kinet
compar
wild
type
explan
discrep
could
abil
replic
complex
receiv
process
nucleotid
increas
rate
due
chang
structur
arrang
replic
complex
thu
greater
abil
access
process
necessari
compon
rna
synthesi
still
possess
highfidel
state
nonetheless
result
contradict
observ
polymeras
make
fewer
error
gener
manifest
slower
polymer
rate
also
possibl
contrast
result
caus
technic
differ
assay
use
sinc
correct
nucleotid
incorpor
assay
use
synthet
substrat
purifi
polymeras
isol
abbrevi
nucleotid
incorpor
cycl
regardless
like
replicas
function
fidel
regul
nucleotid
access
multipl
level
includ
rna
structur
replicas
proteinprotein
interact
process
rnaprotein
interact
host
compon
area
need
address
fulli
understand
replicas
fidel
addit
increas
kinet
optim
condit
address
activ
highfidel
replic
complex
low
nucleotid
condit
found
nucleotid
level
reduc
highfidel
replic
complex
activ
reduc
greater
extent
wild
type
yet
still
capabl
synthes
rna
turn
overcom
low
nucleotid
level
specul
variant
adopt
fine
calibr
replic
complex
allow
greater
access
incom
nucleotid
necessari
compon
higher
process
nucleotid
encount
basi
vitro
biochem
studi
given
pleiotrop
effect
ribavirin
address
resist
highfidel
variant
compound
deplet
intracellular
nucleotid
level
yet
report
nucleosid
analogu
mycophenol
acid
brequinar
found
highfidel
variant
resist
antivir
effect
mycophenol
acid
better
wt
chikv
wherea
variant
confer
resist
brequinar
addit
viral
growth
could
rescu
addit
relev
exogen
nucleosid
result
tissu
cultur
support
vitro
biochem
result
highfidel
variant
abl
function
better
presenc
low
level
nucleotid
particular
resist
brequinar
pyrimidin
deplet
may
explain
enhanc
ntpase
activ
variant
pyrimidin
ctp
utp
furthermor
sinc
abl
complet
restor
viru
titer
drug
treatment
addit
exogen
nucleotid
data
suggest
compound
may
effect
rna
mutagen
natur
nucleotid
pool
concomitantli
deplet
observ
support
abil
complement
mutagen
effect
ribavirin
mycophenol
acid
addit
relev
nucleosid
summari
show
essenti
role
novel
function
maintain
alphaviru
replic
complex
fidel
furthermor
evid
support
longstand
hypothesi
concert
dynam
interact
viral
helicas
polymeras
orchestr
replic
fidel
studi
highlight
mechan
rna
virus
respond
intracellular
environ
replic
fidel
low
nucleotid
concentr
given
mani
nucleosid
analog
rna
mutagen
alreadi
use
consid
clinic
set
understand
mechan
increas
mutat
rate
facilit
use
broadspectrum
antivir
